Document is current
Any future updates will be listed below
-
Authors
Binder, H. http://orcid.org/0000-0002-2242-4678
Willscher, E.
Loeffler-Wirth, H.
Hopp, L.
Jones, D. T. W.
Pfister, S. M.
Kreuz, M.
Gramatzki, D.
Fortenbacher, E.
Hentschel, B.
Tatagiba, M.
Herrlinger, U.
Vatter, H.
Matschke, J.
Westphal, M.
Krex, D.
Schackert, G.
Tonn, J. C.
Schlegel, U.
Steiger, H.-J.
Wick, W.
Weber, R. G.
Weller, M.
Loeffler, M.
- License Information
-
More Information
Article History
Received: 17 January 2019
Accepted: 18 March 2019
First Online: 25 April 2019
Ethics approval and consent to participate
: All patients gave written informed consent for participation in the GGN and its translational research projects.
: Not applicable.
: MW has received research grants from Abbvie, Acceleron, Actelion, Bayer, Merck, Sharp & Dohme (MSD), Merck (EMD), Novocure, OGD2, Piqur, Roche and Tragara, and honoraria for lectures or advisory board participation or consulting from Abbvie, BMS, Celgene, Celldex, Merck, Sharp & Dohme (MSD), Merck (EMD), Novocure, Orbus, Pfizer, Progenics, Roche, Teva and Tocagen. US has received honoraria for lectures or advisory board participation from medac, GSK, mundipharma, Novartis, Novocure, Roche. DK has received research grants from Novocure, Northwest biotherapeutics, Kyowa, and honoraria for lectures or advisory board participation or consulting from Baxter and Kyowa. WW received study drug for clinical research from Apogenix, Roche and Pfizer. JCT has received research grants BrainLab and honoraria for lectures from BrainLab, Siemens, Merck, Roche and medac.All other authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
